BI 3814916

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 3814916, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test How Different Doses of BI 3814916 Are Tolerated by Healthy People [Phase 1]